ALX Oncology (ALXO) Files $450M Mixed Shelf
- Wall Street ends mixed after punishing week
- '3600 is the New Bull Case': Outflows from Energy and Materials Highest in Several Years - BofA
- Dollar catches a break after bruising week as investors turn risk averse
- Apple (AAPL) is a 'Compelling Name To Own' Right Now, iPhone Sales Trending Ahead of Guidance - Wedbush's Ives
- Deere (DE) Falls on Sales Miss, JPMorgan Sees 'Aggressive' Guidance and Downside Risk
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
ALX Oncology (NASDAQ: ALXO) has filed $450,000,000 mixed shelf of:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ALX Oncology (ALXO) PT Lowered to $48 at Piper Sandler
- Regeneron (REGN), Sanofi (SNY) Confirm FDA Approves Dupixent as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis
- Century Aluminum Co (CENX) Files Mixed Shelf
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!